Publications by authors named "Jean-Claude Bizec"

Claim this Profile
D
Determination and application of the permitted daily exposure (PDE) for topical ocular drugs in multipurpose manufacturing facilities.
Ester Lovsin Barle, Jean-Claude Bizec, Milica Glogovac, Kamila Gromek, Gian Christian Winkler

Pharm Dev Technol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Discovery of N-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration.
Christopher M Adams, Karen Anderson, Gerald Artman, Jean-Claude Bizec, Rosemarie Cepeda

J Med Chem· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and technical comparison of Sandostatin® LAR® and other formulations of long-acting octreotide.
Holger Petersen, Jean-Claude Bizec, Helmut Schuetz, Marie-Laure Delporte

BMC Res Notes· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis